(Q42905765)

10 November 2017

title

Effects of alendronate on bone healing after tooth extraction in rats (English)

1 reference

10 November 2017

J. I. Aguirre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

M. K. Altman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

S. M. Vanegas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

S. E. Franz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

A. C F. Bassit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

T. J. Wronski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846154

14 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846154

14 July 2024

publication date

1 October 2010

1 reference

full work available at URL

10 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1601-0825.2010.01677.x

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1601-0825.2010.01677.x/fullpdf

14 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

14 July 2024

1 reference

10 November 2017

volume

16

1 reference

10 November 2017

issue

7

1 reference

10 November 2017

page(s)

674-685

1 reference

Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2010.01677.X

Ridge remodeling after tooth extraction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2010.01677.X

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2010.01677.X

Animal models of osteonecrosis of the jaw

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The effect of alendronate on resorption of the alveolar bone following tooth extraction

14 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The age factor in human extraction wound healing

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Age factor in human alveolar bone repair

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Osteonecrosis of the jaw--do bisphosphonates pose a risk?

14 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Ten years' experience with alendronate for osteoporosis in postmenopausal women

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vascular biology and the skeleton

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo

14 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Angiogenesis and bone repair

14 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Dynamics of bone tissue formation in tooth extraction sites. An experimental study in dogs

14 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

14 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Cellular and molecular characterization of a murine non-union model

14 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

14 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats

14 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Effect of alendronate on cultured normal human osteoblasts

14 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Angiogenesis in fracture repair

14 July 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells

14 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The progress of the periodontal syndrome in the rice rat. I. Morphometric and autoradiographic studies

14 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The progress of the periodontal syndrome in the rice cat. II. The effects of a diphosphonate on the periodontium

14 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

[Periodontal disease in the rice rat. I. Anatomic and histopathologic findings]

14 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells

14 July 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Predictors of outcome of floating knee injuries in adults: 89 patients followed for 2-12 years.

14 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bis-phossy jaw, phossy jaw, and the 21st century: Bisphosphonate-associated complications of the jaws

14 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats

14 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The healing process following molar extraction. I. Normal male rats (long-evans strain)

14 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats

14 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

14 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients

14 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Repair of the post-extraction alveolus in the Wistar rat. A histologic and autoradiographic study

14 July 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats

14 July 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Diphosphonates inhibit human osteoblast secretion and proliferation

14 July 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

14 July 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates

14 July 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vascular endothelial growth factor is a secreted angiogenic mitogen

14 July 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vascular endothelial growth factor (VEGF) response to dental trauma: a preliminary study in rats

14 July 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Differentiation of periodontal ligament fibroblasts into osteoblasts during socket healing after tooth extraction in the rat

14 July 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

14 July 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

14 July 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

14 July 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

14 July 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts

14 July 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

14 July 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts

14 July 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

14 July 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment

14 July 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Reduced COX-2 expression in aged mice is associated with impaired fracture healing.

14 July 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

14 July 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Pharmacokinetics of alendronate

14 July 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts

14 July 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate mechanism of action

14 July 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonates: mechanisms of action

14 July 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Preclinical pharmacology of alendronate

14 July 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

14 July 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

14 July 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

14 July 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

14 July 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Inhibitory effects of a bisphosphonate (risedronate) on experimental periodontitis in rats

14 July 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

A comparative histological and radiographic study of extraction socket healing in the rat

14 July 2024

80

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients

14 July 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

The healing socket and socket regeneration

14 July 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

14 July 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats

14 July 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells

14 July 2024

85

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys

14 July 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

14 July 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

14 July 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1601-0825.2010.01677.X

14 July 2024

Identifiers

1 reference

10 November 2017

1 reference